Rituximab after ASCT prolongs survival for young MCL patients
5 Dec 2016
Rituximab after ASCT prolongs survival for young MCL patients
How can we use crenolanib to treat AML?
Highlights in myeloid leukaemia research from ASH 2016
Thromboembolytic risks of central venous catheters in paediatric patients
Pure erythroid leukaemias
Clinical updates for guadecitabine and vorinostat
ALL: Combining paediatric-type therapy with minimal residual disease
ASH 2016: AML, CLL and leukaemogenesis latest
Vosaroxin for relapsed AML: Updates from VALOR
Impact of next-generation sequencing on treatment choice for MDS
Obinutuzumab extends PFS for follicular lymphoma in GALLIUM trial
Venetoclax plus cytarabine in elderly AML patients